Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 8, 2012, Pages 881-886

  Adjemian, Jennifer ^a   Olivier, Kenneth N ^a   Seitz, Amy E ^a   Holland, Steven M ^a   Prevots, D Rebecca ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Epidemiology; Nontuberculous mycobacteria; Prevalence; Pulmonary; United States

Indexed keywords

AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; COMORBIDITY; DEMOGRAPHY; ETHNICITY; FEMALE; GEOGRAPHY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICARE; PRIORITY JOURNAL; PULMONARY NONTUBERCULOUS MYCOBACTERIA DISEASE; UNITED STATES;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84860200716     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201111-2016OC     Document Type: Article

References (52)

1. Falkinham JO. Impact of human activities on the ecology of nontuberculous mycobacteria. Future Microbiol 2010;5:951-960.
2. Mangione EJ, Huitt G, Lenaway D, Beebe J, Bailey A, Figoski M, Rau MP, Albrecht KD, Yakrus MA. Nontuberculous mycobacterial disease following hot tub exposure. Emerg Infect Dis 2001;7:1039-1042. (Pubitemid 33115790)
3. Tortoli E. Clinical manifestations of nontuberculous mycobacteria infections. Clin Microbiol Infect 2009;15:906-910.
4. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 2010;182:970-976.
5. Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, Holland SM, Prevots DR. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009;15:1562-1569.
6. Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008;14:390-396. (Pubitemid 351451385)
7. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008;178:1066-1074.
8. Adjemian J, Olivier K, Seitz A, Holland S, Prevots R. Prevalence of pulmonary nontuberculous mycobacterial infections among U.S. Medicare beneficiaries, 1997-2007. Presented at the Annual Meeting of the American Thoracic Society, May, 2011, Denver, CO.
9. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 2000.
10. United States Census Bureau. Table DP-1. Profile of general demographic characteristics: 2000. Geographic area: United States. Washington, DC: United States Census Bureau; 2000.
11. Colello K. Where do older Americans live? Geographic distribution of the older population. Washington, DC: Domestic Social Policy Division, Congressional Research Service; 2007.
12. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006;129:1653-1672. (Pubitemid 43894999)
13. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566-581. (Pubitemid 39093445)
14. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
15. du Moulin GC, Sherman IH, Hoaglin DC, Stottmeier KD. Mycobacterium avium complex, an emerging pathogen in Massachusetts. J Clin Microbiol 1985;22:9-12. (Pubitemid 15032662)
16. Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011;20:229-235.
17. Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010;16:1576-1583.
18. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis 2000;31:958-967.
19. Pang SC. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med 1991;85:213-218.
20. Wang HX, Yue J, Han M, Yang JH, Gao RL, Jing LJ, Yang SS, Zhao YL. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008. Chin Med J (Engl) 2010;123:184-187.
21. Ding LW, Lai CC, Lee LN, Hsueh PR. Disease caused by nontuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect 2006;134:1060-1067. (Pubitemid 44336383)
22. Sakatani M. [The epidemiology of pulmonary disease caused by mycobacterium avium complex in Japan]. Kekkaku 1993;68:43-46.
23. Park YS, Lee CH, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010;14:1069-1071.
24. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007;62:661-666. (Pubitemid 47235003)
25. Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of urban tuberculosis in the United States, 2000-2007. Am J Public Health 2011;101:1256-1263.
26. Horsburgh CR, Hanson DL, Jones JL, Thompson SE. Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. J Infect Dis 1996; 174:1212-1217. (Pubitemid 26393899)
27. Sickbert-Bennett EE, Weber DJ, Poole C, MacDonald PD, Maillard JM. Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. Am J Epidemiol 2010;172:1299-1305.
28. Seitz A, Olivier K, Adjemian J, Holland S, Prevots R. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000-2007. Chest (In press)
29. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009;15:1556-1561.
30. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2002. MMWR Morb Mortal Wkly Rep 2004;53:427-431.
31. Centers for Disease Control and Prevention. From the Center for Disease Control and Prevention. Cigarette smoking among adults-United States, 1998. JAMA 2000;284:2180-2181.
32. Centers for Disease Control and Prevention. Use of race and ethnicity in public health surveillance: summary of the CDC/ATSDR workshop. MMWR Recomm Rep 1993;42:1-16.
33. Bitton A, Zaslavsky AM, Ayanian JZ. Health risks, chronic diseases, and access to care among us pacific islanders. J Gen Intern Med 2010;25:435-440.
34. Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S. Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 2000;162:316-318. (Pubitemid 30469839)
35. Good RC. From the Center for Disease Control. Isolation of nontuberculous mycobacteria in the United States, 1979. J Infect Dis 1980;142:779-783. (Pubitemid 11138439)
36. Hennessee CT, Seo JS, Alvarez AM, Li QX. Polycyclic aromatic hydrocarbon-degrading species isolated from Hawaiian soils: Mycobacterium crocinum sp. nov., mycobacterium pallens sp. nov., mycobacterium rutilum sp. nov., mycobacterium rufum sp. nov. And mycobacterium aromaticivorans sp. nov. Int J Syst Evol Microbiol 2009;59:378-387.
37. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99:1-132.
38. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834. (Pubitemid 36801769)
39. Kirschner RA Jr, Parker BC, Falkinham JO 3rd. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis 1992;145:271-275.
40. Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-551.
41. Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011;17:419-424.
42. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-982.
43. Marras TK, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 2010;188:289-299.
44. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16.
45. Sohn H, Kim HJ, Jung Kwon O, Koh WJ, Shin SJ. High virulent clinical isolates of mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. Microb Pathog 2009;47:321-328.
46. Escarce JJ, Epstein KR, Colby DC, Schwartz JS. Racial differences in the elderly's use of medical procedures and diagnostic tests. Am J Public Health 1993;83:948-954. (Pubitemid 23211980)
47. Chen LM. Is there disparity in physician service use? A comparison of Hispanic and white medicare beneficiaries. Health Soc Work 2010;35:181-190.
48. Virnig BA, Lurie N, Huang Z, Musgrave D, McBean AM, Dowd B. Racial variation in quality of care among medicare1choice enrollees. Health Aff (Millwood) 2002;21:224-230.
49. Semrad TJ, Tancredi DJ, Baldwin LM, Green P, Fenton JJ. Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees. Cancer 2011;117:1755-1763.
50. White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer 2010;116:4622-4631.
51. Moy E, Greenberg LG, Borsky AE. Community variation: disparities in health care quality between Asian and white medicare beneficiaries. Health Aff (Millwood) 2008;27:538-549. (Pubitemid 351490346)
52. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 2008;112:171-180.